(142 days)
Not Found
No
The document describes a standard multiparameter patient monitor and does not mention any AI or ML capabilities in the intended use, device description, or performance studies.
No.
The device is described as a "patient monitor" intended for "monitoring, displaying, reviewing, and transferring multiple physiological parameters," which indicates it is a diagnostic or monitoring device, not one that directly treats or heals.
No
This device is described as a patient monitor family used for monitoring, displaying, reviewing, and transferring multiple physiological parameters. It does not perform a diagnostic function but rather provides data for clinicians to use.
No
The device description explicitly states that the uMEC Series Patient Monitors are designed with a platform of both software and hardware.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The uMEC Series Patient Monitors are described as devices that monitor, display, review, and transfer physiological parameters directly from the patient (ECG, respiration, temperature, SpO2, NIBP, IBP, C.O., CO2). These are measurements taken in vivo (within the living body), not in vitro (in a test tube or lab setting).
- Intended Use: The intended use clearly states monitoring of physiological parameters on patients, not testing of samples.
Therefore, the uMEC Series Patient Monitors fall under the category of patient monitoring devices, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The uMEC Series Patient Monitor family consists of the uMEC7, uMEC10, uMEC12, uMEC15 and uMEC15S patient monitors. All of the devices in the family are multiparameter monitors indicated for monitoring, displaying, reviewing, and transferring multiple physiological parameters. The specific indications for use are provided below.
The uMEC series patient monitors are intended for monitoring, displaying, and transferring of multiple physiological parameters including ECG (3-lead or 12-lead selectable, arrhythmia detection, ST segment analysis, QT analysis, and heart rate (HR)), respiration rate (Resp), temperature (Temp), pulse oxygen saturation (SpO2), pulse rate (PR), non-invasive blood pressure (NIBP), invasive blood pressure(IBP), cardiac output (C.O.), carbon dioxide (CO2).
All the parameters can be monitored on single adult, pediatric, and neonatal patients with the exception of the following: The arrhythmia detection and SpO2 are intended for adult and pediatric patients only; ST Segment analysis is intended for adult patients only; and C.O. monitoring is restricted to adult patients only.
The monitor is to be used in healthcare facilities by clinical professionals or under their guidance.
Product codes (comma separated list FDA assigned to the subject device)
MHX, DSI, MLD, DRT, DXN, DSK, FLL, DQA, CCK, DXG, DSJ, DRS
Device Description
The subject uMEC Series Patient Monitors include six monitors:
- uMEC6 Patient Monitor
- uMEC7 Patient Monitor
- uMEC10 Patient Monitor
- uMEC12 Patient Monitor
- uMEC15 Patient Monitor
- uMEC15S Patient Monitor
The uMEC Series Patient Monitors are Mindray's new generation monitoring product family with ergonomic and flexible design in platform of both software and hardware to meet the clinical needs of monitoring.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult, pediatric, and neonatal patients.
With the exception of:
- Arrhythmia detection and SpO2 are intended for adult and pediatric patients only.
- ST Segment analysis is intended for adult patients only.
- C.O. monitoring is restricted to adult patients only.
Intended User / Care Setting
Healthcare facilities by clinical professionals or under their guidance.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Mindray conducted functional and system level testing on the subject device to establish the substantial equivalence. The testing provided an evaluation of the performance of the device relevant to each of the differences between the subject device and the predicate device. The functional and system level testing showed that the devices continue to meet specifications and the performance of the device is equivalent to the predicate.
Mindray has conducted testing to ensure the subject device meets relevant consensus standards.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath.
November 15, 2017
Shenzhen Mindray Bio-Medical Electronics Co., Ltd Yanhong Bai Manager Regulatory Affairs Mindray Building, Keji 12th Road South, Hi-tech Industrial Park, Nanshan Shenzhen, 518057 CN
Re: K171901
Trade/Device Name: uMEC Series Patient Monitors (including uMEC6, uMEC7, uMEC12, uMEC15, uMEC15S) Regulation Number: 21 CFR 870.1025 Regulation Name: Arrhythmia Detector And Alarm (Including St-Segment Measurement And Alarm) Regulatory Class: Class II Product Code: MHX, DSI, MLD, DRT, DXN, DSK, FLL, DQA, CCK, DXG, DSJ, DRS Dated: October 11, 2017 Received: October 16, 2017
Dear Yanhong Bai:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
1
801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerelv.
M& Millelreme
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K171901
Device Name
uMEC Series Patient Monitors (including uMEC6, uMEC7, uMEC12, uMEC12, uMEC15, uMEC15S)
Indications for Use (Describe)
The uMEC Series Patient Monitor family consists of the uMEC7, uMEC10, uMEC12, uMEC15 and uMEC15S patient monitors. All of the devices in the family are multiparameter monitors indicated for monitoring, displaying, reviewing, and transferring multiple physiological parameters. The specific indications for use are provided below.
The uMEC series patient monitors are intended for monitoring, displaying, and transferring of multiple physiological parameters including ECG (3-lead or 12-lead selectable, arrhythmia detection, ST segment analysis, QT analysis, and heart rate (HR)), respiration rate (Resp), temperature (Temp), pulse oxygen saturation (SpO2), pulse rate (PR), non-invasive blood pressure (NIBP), invasive blood pressure(IBP), cardiac output (C.O.), carbon dioxide (CO2).
All the parameters can be monitored on single adult, pediatric, and neonatal patients with the exception of the following: The arrhythmia detection and SpO2 are intended for adult and pediatric patients only;
ST Segment analysis is intended for adult patients only; and
C.O. monitoring is restricted to adult patients only.
The monitor is to be used in healthcare facilities by clinical professionals or under their guidance.
Type of Use (Select one or both, as applicable) | |
---|---|
X Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(K) SUMMARY
In accordance with 21 CFR 807.87(h) and (21 CFR 807.92) the 510(k) Summary for the uMEC series patient monitors is provided below.
Device Common Name: | Patient Monitor |
---|---|
Device Trade Name: | uMEC Series Patient Monitors(including uMEC6, uMEC7, uMEC10, uMEC12, uMEC15, uMEC15S) |
Applicant: | SHENZHEN MINDRAY BIO-MEDICAL |
ELECTRONICS CO., LTD. | |
Mindray Building, Keji 12th Road South | |
High-tech Industrial Park, Nanshan | |
Shenzhen 518057, P.R. China | |
Tel: +86 755 81888998 | |
Fax: +86 755 26582680 | |
Contact: | Yanhong Bai |
Manager Regulatory Affairs | |
SHENZHEN MINDRAY BIO-MEDICAL | |
ELECTRONICS CO., LTD. | |
Mindray Building, Keji 12th Road South | |
High-tech Industrial Park, Nanshan 518057, P.R. China | |
Tel: +86 755 81885635 | |
Fax: +86 755 26582680 | |
E-mail: baiyanhong@mindray.com | |
Date Prepared: | June 23, 2017 |
Classification Regulation: | 870.1025 - Arrhythmia detector and alarm (including |
ST-segment measurement and alarm) | |
Class II | |
Panel: | Cardiovascular |
Product Code: | MHX - monitor, physiological, patient (with arrhythmia |
detection or alarms) |
4
Subsequent Product Codes:
| Product
Code | Regulation
Number | Panel | Regulation description | Device Common Name |
|-----------------|----------------------|----------------|----------------------------------------------------------------------------|--------------------------------------------------------------|
| DSI | 21 CFR
870.1025 | Cardiovascular | Arrhythmia detector and alarm (including ST-segment measurement and alarm) | detector and alarm,
arrhythmia |
| MLD | 21 CFR
870.1025 | Cardiovascular | Arrhythmia detector and alarm (including ST-segment measurement and alarm) | monitor, st segment with
alarm |
| DRT | 21 CFR
870.2300 | Cardiovascular | Cardiac Monitor (including cardiotachometer and rate alarm) | monitor, cardiac (incl.
cardiotachometer & rate
alarm) |
| DXN | 21 CFR
870.1130 | Cardiovascular | Noninvasive blood pressure measurement system | system, measurement
, blood-pressure, |
| DSK | 21 CFR
870.1110 | Cardiovascular | Blood pressure computer | computer, blood-pressure |
| FLL | 21 CFR
880.2910 | Cardiovascular | Clinical electronic thermometer | thermometer, electronic,
clinical |
| DQA | 21 CFR
870.2700 | Cardiovascular | Oximeter | oximeter |
| CCK | 21 CFR
868.1400 | Anesthesiology | Carbon dioxide gas analyzer | analyzer, gas,
carbon-dioxide, |
| DXG | 21 CFR
870.1435 | Cardiovascular | Single-function, preprogrammed diagnostic | computer, diagnostic,
pre-programmed, |
| DSJ | 21 CFR
870.1100 | Cardiovascular | Blood pressure alarm | alarm, blood-pressure |
| DRS | 21 CFR
870.2850 | Cardiovascular | transducer, blood-pressure, extravascular | Extravascular blood
pressure transducer. |
Predicate Device: K152902 –Passport Series Patient Monitors
Indication for Use:
The uMEC Series Patient Monitor family consists of the uMEC6, uMEC7, uMEC10, uMEC12, uMEC15 and uMEC15S patient monitors. All of the devices in the family are multiparameter monitors indicated for monitoring, displaying, reviewing, and transferring multiple physiological parameters. The specific indications for use are provided below.
The uMEC series patient monitors are intended for monitoring, displaying, reviewing, and K171901
5
transferring of multiple physiological parameters including ECG (3-lead , 5-lead or 12-lead selectable, arrhythmia detection, ST segment analysis, and heart rate (HR)), respiration rate (Resp), temperature (Temp), pulse oxygen saturation (SpO2), pulse rate (PR), non-invasive blood pressure (NIBP), invasive blood pressure(IBP), cardiac output (C.O.), carbon dioxide (CO2).
All the parameters can be monitored on single adult, pediatric, and neonatal patients with the exception of the following:
The arrhythmia detection and SpO2 are intended for adult and pediatric patients only; ST Segment analysis is intended for adult patients only;
C.O. monitoring is restricted to adult patients only;
The monitor is to be used in healthcare facilities by clinical professionals or under their guidance.
Device Description:
The subject uMEC Series Patient Monitors include six monitors:
- uMEC6 Patient Monitor ●
- . uMEC7 Patient Monitor
- . uMEC10 Patient Monitor
- uMEC12 Patient Monitor
- uMEC15 Patient Monitor
- uMEC15S Patient Monitor ●
The uMEC Series Patient Monitors are Mindray's new generation monitoring product family with ergonomic and flexible design in platform of both software and hardware to meet the clinical needs of monitoring.
Performance Data:
- To establish the substantial equivalence of the uMEC Series Patient Monitors, Mindray conducted functional and system level testing on the subject device. The testing provided an evaluation of the performance of the device relevant to each of the differences between the subject device and the predicate device. The functional and system level testing showed that the devices continue to meet specifications and the performance of the device is equivalent to the predicate.
- Mindray has followed the following FDA Guidance Documents relevant to this device: .
- Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm Guidance for Industry and FDA (10/28/2003)
- Cardiac Monitor Guidance (Including Cardiotachometer and Rate Alarm)
- . Mindray has conducted testing to ensure the subject device meets relevant consensus standards.
6
ANSVAAMI ES60601-1:2005/(R)2012 and A1:2012,C1:2009/(R)2012 and A2:2010/(R)2012 Medical electrical equipment--Part 1:General requirements for basic safety and essential performance
IEC 60601-1-2:2007 Medical electrical equipment--Part 1-2: General requirements for basic safety and essential performance-- Collateral standard: Electromagnetic compatibility--Requirements and tests
IEC 60601-1-8:2012 Medical electrical equipment - part 1-8: general requirements for basic safety and essential performance - collateral standard: general requirements, tests and guidance for alarm systems in medical electrical equipment and medical electrical systems
IEC 60601-1-6: 2013 Medical electrical equipment-part 1-6: general requirements for basic safety and essential performance--collateral standard: usability
IEC 60601-2-49:2011 Medical electrical equipment --Part 2-49: Particular requirements for the basic safety and essential performance of multifunction patient monitoring equipment
IEC 60601-2-27:2011 Medical electrical equipment--Part 2-27: Particular requirements for the basic safety and essential performance of electrocardiographic monitoring equipment
IEC 60601-2-34:2011 Medical electrical equipment - part 2-34: particular requirements for the basic safety, including essential performance, of invasive blood pressure monitoring equipment
IEC 80601-2-30:2013 Medical electrical equipment - part 2-30: particular requirements for the basic safety and essential performance of automated non-invasive sphygmomanometers
ISO 80601-2-56: 2009 Medical electrical equipment - part 2-56: particular requirements for basic safety and essential performance of clinical thermometers for body temperature measurement
ISO 80601-2-61: 2011 Medical electrical equipment - part 2-61: particular requirements for basic safety and essential performance of pulse oximeter equipment
ISO 80601-2-55: 2011 Medical electrical equipment - part 2-55: particular requirements for the basic safety and essential performance of respiratory gas monitors
AAMI / ANSI EC57:2012 testing and reporting performance results of cardiac rhythm and stsegment measurement algorithms
IEC 62133 : 2012 secondary cells and batteries containing alkaline or other non-acid electrolytes safety requirements for portable sealed secondary cells, and for batteries made from them, for use in portable applications
Comparison of Indications:
Both the predicate device and the subject uMEC Series Patient Monitors are multiparameter patient monitors intended to be used in healthcare facilities under the direction of clinical professionals. Some features present in the cleared Passport Series Patient Monitors are not present in uMEC Series Patient Monitors. In conclusion, the minor differences to the indications K171901
7
for use do not change the fundamental intended use of the uMEC series Patient Monitors as multiparameter monitors.
Comparison of Technological Characteristics:
The technological characteristics of the subject device are compared to the predicate device in the table below.
Predicate Device (K152902) | Subject Devices | ||||||
---|---|---|---|---|---|---|---|
Feature | Passport 17m | uMEC6 | uMEC10 | uMEC7 | uMEC12 | uMEC15 | uMEC15S |
Integrated | |||||||
display and | |||||||
touchscreen | 17" 1280*1024 pixels | 10.4" | |||||
800*600 | |||||||
pixels | 10.4" | ||||||
800*600 pixels | 12.1" | ||||||
800*600 pixels | 12.1" | ||||||
800*600 pixels | 15" | ||||||
1024*768 | |||||||
pixels | 15" | ||||||
1024*768 pixels | |||||||
Power | |||||||
supply | Two rechargeable Lithium-ion battery | ||||||
or AC power supply | One standard Rechargeable Lithium-ion battery or One optional | ||||||
Rechargeable Lithium-ion battery or | |||||||
AC power supply | |||||||
Battery | Chargeable Lithium-Ion, 11.1 VDC, | ||||||
4500 mAh | Chargeable Lithium-Ion, 11.1 VDC, 2500 mAh (Standard) | ||||||
Chargeable Lithium-Ion, 11.1 VDC, 5000 mAh (Optional ) | |||||||
Data | |||||||
Recorder | The thermal recorder records patient | ||||||
information, measurement numerics, | |||||||
up to three waveforms, etc. | Same | ||||||
Speaker | Give alarm tones (45 to 85 dB), key | ||||||
tones, QRS tones; support PITCH | |||||||
TONE and multi-level tone | |||||||
modulation | Same | ||||||
ECG | 3-lead , 5-lead or 12-lead selectable, | ||||||
arrhythmia detection, ST segment | |||||||
analysis, QT analysis, an interpretation | |||||||
of resting 12-lead ECG, and heart rate | |||||||
(HR); | |||||||
Support Mindray and Mortara | |||||||
algorithm. | 3-lead , 5-lead or 12-lead selectable, arrhythmia detection, ST | ||||||
segment analysis, QT analysis andheart rate (HR); | |||||||
Only support Mindray algorithm and don't support interpretation | |||||||
of resting 12-lead ECG | |||||||
ECG | |||||||
measurement | |||||||
range | |||||||
and | |||||||
Accuracy | HR: Neonate: 15 to 350 bpm; | ||||||
Pediatric: 15 to 350 bpm; | |||||||
Adult: 15 to 300 bpm; | |||||||
±1 bpm or ±1%, whichever is greater. |
ST: -2.0 to 2.0 mV RTI;
-0.8 to 0.8 mV: ±0.02 mV or ±10%,
whichever is greater.
Beyond this range: Not specified.
QT: [200, 800]ms; ±30ms | Same | | | | | |
| Arrhythmia
Analysis | Asystole, VFib/VTac, Vtac, Vent.
Brady, ExtremeTechy, Extreme
Brady, PVC, Couplet, Bigeminy,
Trigeminy, R on T, RunPVCs,PVCs,
Tachy, Brady, Missed Beats, Vent.
Rhythm, PNP, PNC, Multif.
PVC,Nonsus. Vtac, Pause, Irr.
Rhythm, Afib | Same | | | | | |
| | Predicate Device (K152902) | Subject Devices | | | | | |
| Feature | Passport 17m | uMEC6 | uMEC1
0 | uMEC
7 | uMEC1
2 | uMEC1
5 | uMEC15
S |
| Respiration
rate (Resp) | Measurement range: Adult: 0 to 120
rpm; Pediatric, neonate: 0 to 150 rpm.
Accuracy: 7 to 150 rpm: ±2 rpm or
±2%, whichever is greater;
0 to 6 rpm: Not specified. | Same | | | | | |
| Temperatur
e (Temp) | Measurement range: 0 to 50 °C (32 to
122 F)
Accuracy: ±0.1 °C or ±0.2 F (without
probe) | Same | | | | | |
| Pulse
oxygen
saturation
(SpO2) | MindraySpO2 Module
Measurement range: 0 to 100%
Accuracy:70 to 100%: ±2%
(adult/pediatric mode)
70 to 100%: ±3% (neonate mode)
0% to 69%: Not specified.
MasimoSpO2 Module
Measurement range: 1 to 100%
Accuracy:70 to 100%: ±2% (measured
without motion in adult/pediatric
mode)
70 to 100%: ±3% (measured without
motion in neonate mode)
70 to 100%: ±3% (measured with
motion)
1% to 69%: Not specified.
NellcorSpO2 Module
Measurement range: 0 to 100%
Accuracy:70 to 100%: ±2%
(adult/pediatric)
70 to 100%: ±3% (neonate)
0% to 69%: Not specified. | MindraySpO2 Module
Measurement range: 0 to 100%
Accuracy:70 to 100%: ±2% (adult/pediatric mode)
0% to 69%: Not specified.
MindraySpO2 Module do not support neonate mode and the
specifications for Adult/pediatric are same
Not Support Masimo and NellcorSpO2 Module | | | | | |
| Pulse rate
(PR) | PR from MindraySpO2 Module
Measurement range: 20 to 254 bpm
Accuracy: ±3 bpm
PR from MasimoSpO2 Module
Measurement range: 25 to 240 bpm
Accuracy: ±3 bpm (measured without
motion)
±5 bpm (measured with motion)
PR from NellcorSpO2 Module
Measurement range: 20 to 300 bpm
Accuracy:20 to 250 bpm: ±3 bpm
251 to 300 bpm, not specified
PR from IBP Module
Measurement range: 25 to 350 bpm
Accuracy: ±1 bpm or ±1%, whichever
is greater | PR from
MindraySpO2
Module
Measurement
range: 20 to 254
bpm
Accuracy:±3 bpm
PR specifications
from MindraySpO2
module are same
Not Support
Masimo and
NellcorSpO2
Module | | PR from MindraySpO2 Module
Measurement range: 20 to 254 bpm
Accuracy: ±3 bpm | PR from IBP Module
Measurement range: 25 to 350 bpm
Accuracy: ±1 bpm or ±1%, whichever is
greater | PR specifications from MindraySpO2
module and IBP Module are same
Not Support Masimo and NellcorSpO2
Module | |
8
9
Predicate Device (K152902) | Subject Devices | ||||||||
---|---|---|---|---|---|---|---|---|---|
Feature | Passport 17m | uMEC6 | |||||||
0 | uMEC1 | ||||||||
7 | uMEC1 | ||||||||
2 | uMEC1 | ||||||||
5 | uMEC15 | ||||||||
S | |||||||||
Non- | |||||||||
invasive | |||||||||
blood | |||||||||
pressure | |||||||||
(NIBP) | Measurement range: | Measurement range: | |||||||
Adult | Pediatric | Neonate | Adult | Pediatric | Neonate | ||||
Systolic | 40-270 | 40-200 | 40-135 | 25-290 | 25-240 | 25-140 | |||
Diastolic | 10-210 | 10-150 | 10-100 | 10-250 | 10-200 | 10-115 | |||
Mean | 20-230 | 20-165 | 20-110 | 15-260 | 15-215 | 15-125 | |||
Accuracy: | |||||||||
Max mean error: ±5 mmHg | |||||||||
Max standard deviation: 8 mmHg | Accuracy: | ||||||||
Max mean error: ±5 mmHg | |||||||||
Max standard deviation: 8 mmHg | |||||||||
The measurement range of subject devices is wider than the | |||||||||
predicate device | |||||||||
Invasive | |||||||||
blood | |||||||||
pressure | |||||||||
(IBP) | Measurement range: -50 to 300 mmHg | ||||||||
Accuracy: ±2% or ±1 mmHg, | |||||||||
whichever is greater (without sensor) | Not Supported | Same as the predicate device | |||||||
Cardiac | |||||||||
output | |||||||||
(C.O.) | Measurement range: | ||||||||
C.O: 0.1 to 20 L/min | |||||||||
TB: 23 to 43 °C | |||||||||
TI: 0 to 27 °C | |||||||||
Accuracy | |||||||||
C.O: ±5% or ±0.1 L /min, whichever | |||||||||
is greater | |||||||||
TB, TI: ±0.1 °C (without sensor) | Not Supported | Same as the predicate device |
10
Predicate Device (K152902) | Subject Devices | ||||||
---|---|---|---|---|---|---|---|
Feature | Passport 17m | uMEC6 | uMEC1 | ||||
0 | uMEC1 | ||||||
7 | uMEC1 | ||||||
2 | uMEC1 | ||||||
5 | uMEC15 | ||||||
S | |||||||
Carbon | |||||||
dioxide | |||||||
(CO2) | Sidestream CO2 Module: | ||||||
Measurement range0 - 13% Accuracy: | |||||||
0-5%: ±0.26% abs | |||||||
5-10%: ±5% of the reading | |||||||
10-13%: ±10% of the reading | |||||||
±0.3% ABS increase in error for ISO | |||||||
accuracy mode | |||||||
awRR measurement: | |||||||
awRR measurement range: 0 to | |||||||
120rpm | |||||||
awRR measurement accuracy: ±2rpm | Not Supported | Sidestream CO2 Module: | |||||
Measurement range:0 to 20% | |||||||
Accuracy: | |||||||
CO2 concentration |